Up next

Autoplay

Monoclonal Antibodies – Rituximab & Obinutuzumab | Rebecca Beck, Lymphoma Australia

0 Views • 08/26/25
Share
Side Effects
Side Effects
Subscribers
0

Hosted by Donna Gairns, National Nurse Manager Lymphoma Australia - Rebecca Beck, Lymphoma Care Nurse for NSW discusses what are monoclonal antibodies, how do they work and the common side effects experienced by patients.

Our immune system has antibodies that detect and destroy viruses or bacteria, including abnormal cancer cells. An antibody attaches to a specific molecule (antigen) on the surface of the cell. Once it binds to the antigen, it serves as a flag to attract other immune cells to attack and kill the cell.
Monoclonal antibodies are cancer treatments that are used in the management of many types of B-cell lymphomas. They are made in the laboratory and specially engineered to bind to the CD20 antigens that are on the surface of the malignant and healthy B-cells.
These drugs use the body’s immune system to then attack and fight the cancer cell.

For more information:
Lymphoma Australia fact sheets, including maintenance therapy
https://www.lymphoma.org.au/page/1218/fact-sheets


For more expert presentations, see Lymphoma Australia YouTube Channel

Show more
0 Comments sort Sort By

Up next

Autoplay